Fig. 1 · Structure
Documents & Downloads
Bucolome
Cytochrome P450 Inhibitor
Bucolome is a selective inhibitor of cytochrome P450 2C9 (CYP2C9), primarily used for its uricosuric and anti-inflammatory properties. Its mechanism of action facilitates the increased excretion of uric acid, making it valuable in the research of hyperuricemia and related conditions. Bucolome's modulation of CYP2C9 activity also provides a useful tool for studying drug metabolism and interactions in pharmacological research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 841-73-6 |
| Applications | Cytochrome P450 Inhibitor |
| Formula | C14H22N2O3 |
| Molecular Weight | 266.34 |
| Synonyms | Paramidin; Paramidine |
| SMILES | O=C1NC(C(CCCC)C(N1C2CCCCC2)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.